Cohort Description The Northern Manhattan Study (NOMAS) is a study of the population of Washington Heights in Northern Manhattan. The ongoing study, which began in 1990, has enrolled over 4,400 people, some of whom have suffered a stroke or related neurological syndromes. As the cohort aged, the specific aims grew to include not only vascular determinants of stroke but also cognitive decline, mild cognitive impairment (MCI) and dementia. The overall goal of NOMAS is to investigate stroke risk factors in different race-ethnic groups. NOMAS is also committed to developing better stroke prevention programs to improve the health of the community. The Hispanic population in Northern Manhattan is largely Dominican, along with Puerto Rican, Cuban, and Central and South American components. Data Being Submitted <ul> <li>Wave 1 questionnaire data includes 397 variables for up to 887 NOMAS participants in C4R</li> <li>Wave 2 questionnaire data includes 448 variables for up to 815 NOMAS participants in C4R</li> <li>Derived data includes 43 variables for up to 995 NOMAS participants in C4R</li> <li>Phenotype data includes 113 variables for up to 995 NOMAS participants in C4R</li> </ul>

Collaborative Cohort of Cohorts for COVID-19 Research (C4R): Northern Manhattan Study (NOMAS)

Stroke incidence among white, black, and Hispanic residents of an urban community: the Northern Manhattan Stroke Study.

Collaborative Cohort of Cohorts for COVID-19 Research (C4R) Study: Study Design